Enhancing Survival with Emerging Therapies in HR+/HER2- Breast Cancer
Breast Cancer Survival Rates Survival rates for breast cancer depend on multiple factors, including the stage at diagnosis, tumor subtype, and treatment approach. The five-year survival rate for stage 2 breast cancer is approximately 90%, with slightly lower rates for stage 2B. Progress in HR+ HER2- breast cancer treatment has significantly improved patient outcomes, emphasizing the importance...
0 Комментарии 0 Поделились 225 Просмотры 0 предпросмотр